CA
NZ
UK
AU
IND
US
T-Mobile (Nasdaq:TMUS) delivered a strong Q1 2026Earningsbeat with 11% total serviceRevenuegrowth and raised full-year EBITDA guidance. Network differentiation and ARPA expansion are driving a widening competitive gap.Key HighlightsT-Mobile reported Q1 2026 EPS of $2.27, beating the consensus estimate of $2.05 by 10.73%.Total serviceRevenuegrew 11% …
Visa's (NYSE:V) fiscal Q2 2026Earningsbeat expectations on both EPS andRevenue, with 17% netRevenuegrowth, recordBuybacks, and accelerating value-added services. Here is what the numbers signal for investors.Key HighlightsVisa reported Q2 2026 EPS of $3.31, surpassing the consensus estimate of $3.09 by 7.1%.NetRevenuerose 17% year-over-year to …
In the modern era ofEquitymarkets, few events carry the weight of a single major technologyEarningsrelease. Wednesday's after-market session will feature not one, but four of the most consequential corporate results in the world, arriving simultaneously. Alphabet, Amazon, Microsoft, and Meta Platforms together represent a …
Global oil markets are confronting one of their most acuteSupplyshocks in recent memory. On Wednesday,Brent Crudefutures surged more than 5% to trade above USD 117 per barrel, a level not seen since June 2022. The move reflects mounting anxiety over a conflict involving Iran …
The latest weekly data from the US Energy Information Administration marks more than a routine inventory report. For the first time in recorded weekly data going back to 2001, the United States registered negative net crude imports, with exports of 6.44 million barrels per …
A Rare Respiratory Disease Company Reaches the Public Stage
Celestica Inc. operates within a dynamic segment of the technologySupply/">Supplychain, benefiting from structural tailwinds such as AI-driven infrastructure expansion,Cloud ComputingDemand/">Demand, and industrial automation. Given the stock’s sensitivity toEarnings/">Earningsmomentum,Margin/">Marginexpansion, and macro-driven capex cycles, price movements can be sharp and directional. For traders expecting near-term strength …
Shares of Quantum BioPharma Ltd. (Nasdaq:QNTM) closed at $5.37 in the lastTrading session, advancing 20.67%, after its licensee Unbuzzd Wellness Inc. announced the appointment of Richard Buzbuzian as Chief Executive Officer. The move signals a structural shift from product development toward active commercial deployment, …
Clinical Trialsin rare oncology are rarely forgiving the second time. Soligenix (Nasdaq:SNGX) learned that on April 28, 2026, when its Data Monitoring Committee terminated the Phase 3 FLASH2 study of HyBryte for cutaneous T-cell lymphoma, recommending a halt for futility at the interim efficacy …
AxoGen (Nasdaq:AXGN) closed on April 28 up 6.60%, ending at USD 41.99, as first-quarter 2026 results cleared expectations on theRevenueline by a meaningfulMargin.Revenueof USD 61.5 million surpassed analyst forecasts of USD 57.85 million by 6.24%, driven by broad-basedDemandfor Avance Nerve Graft across the company's …
Please wait processing your request...